Daniela Urina Jassir

Dr. Daniela Urina Jassir

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
JSJason Stencel
Jason Stencel
HAHamid R. Alai
Hamid R. Alai
ADAneesh Dhore-Patil
Aneesh Dhore-Patil
DJDaniela Urina Jassir
Daniela Urina Jassir
TJThierry H. Hubert Le Jemtel
Thierry H. Hubert Le Jemtel
Owing to the overwhelming obesity epidemic, preserved ejection fraction heart failure commonly ensues in patients with severe obesity and the obese phenotype of preserved ejection fraction heart failure is now commonplace in clinical practice. Severe obesity and preserved ejection fraction heart failure share congruent cardiovascular, immune, and renal derangements that make it difficult to ascertain whether the obese phenotype of preserved ejection fraction heart failure is the convergence of two highly prevalent conditions or severe obesity enables the development and progression of the syndrome of preserved ejection fraction heart failure. Nevertheless, the obese phenotype of preserved ejection fraction heart failure provides a unique opportunity to assess whether sustained and sizeable loss of excess body weight via metabolic bariatric surgery reverses the concentric left ventricular remodeling that patients with preserved ejection fraction heart failure commonly display.

20 April 2024 in Current Hypertension Reports
Verified
Journal Article
Open access
PDF file
ADAneesh Dhore-Patil
Aneesh Dhore-Patil
DJDaniela Urina Jassir
Daniela Urina Jassir
RSRohan Samson
Rohan Samson
TJThierry H. Hubert Le Jemtel
Thierry H. Hubert Le Jemtel
SOSuzanne Oparil
Suzanne Oparil
Purpose of the Review: Preserved ejection fraction heart failure and obesity frequently coexist. Whether obesity plays a consistent role in the pathogenesis of preserved ejection fraction heart failure is unclear. Accumulation of visceral adiposity underlies the pathogenic aftermaths of obesity. However, visceral adiposity imaging is assessed by computed tomography or magnetic resonance and thus not routinely available. In contrast, epicardial adiposity thickness is assessed by echocardiography and thus routinely available. We review the rationale for assessing epicardial adiposity thickness in patients with preserved ejection fraction heart failure and elevated body mass index. Recent Findings: Body mass index correlates poorly with visceral, and epicardial adiposity. Visceral and epicardial adiposity enlarges as preserved ejection fraction heart failure progresses. Epicardial adiposity may hasten the progression of coronary artery disease and impairs left ventricular sub-endocardial perfusion and diastolic function. Summary: Epicardial adiposity thickness may help monitor the therapeutic response in patients with preserved ejection failure heart failure and elevated body mass index.

28 December 2018 in Echocardiography
Verified
Journal Article
Closed access
PDF file
NSNicholas Suraci
Nicholas Suraci
SHSofia A. Horvath
Sofia A. Horvath
DJDaniela Urina Jassir
Daniela Urina Jassir
GRGerald Rosen
Gerald Rosen
OSOrlando Santana
Orlando Santana

1 March 2017 in Revista Colombiana de Cardiología
Verified
Journal Article
Open access
MMMirary Mantilla
Mirary Mantilla
MUMiguel Alberto Urina-Triana
Miguel Alberto Urina-Triana
YHYaneth Herazo-Beltrán
Yaneth Herazo-Beltrán
DJDaniela Urina Jassir
Daniela Urina Jassir
ResumenObjetivoDeterminar los efectos de un programa de ejercicio físico sobre las características antropométricas y la capacidad funcional postcirugía de revascularización coronaria o postangioplastia coronaria transluminal percutánea.MétodosEstudio clínico no controlado, de antes y después, en 49 pacientes postcirugía de revascularización coronaria o angioplastia coronaria percutánea. El índice de masa corporal, perímetro abdominal, índice de cintura cadera, perímetro de la cadera y la capacidad cardiorrespiratoria a través de la caminata de los seis minutos fueron evaluados antes y al finalizar el programa de ejercicio físico. Este estuvo conformado por ejercicios aeróbicos continuos, de resistencia muscular, equilibrio y coordinación, durante 3 días a la semana, durante 12 semanas.ResultadosCon relación al perímetro abdominal en las mujeres cambió de 91,4cm a 88,4cm (p=0,003) y en los hombres de 93,6cm a 89,8 (p=0,000). Se logró un incremento significativo de la distancia caminada de 330 a 436 metros (p=0,000); del consumo energético de 3,4 a 4,1 MET (p=0,000); y la máxima capacidad de absorber, transportar y consumir el oxígeno, de 12 a 14ml/Kg/min.ConclusionesEl programa de ejercicio físico que fue utilizado en este estudio, pudo en todos los sujetos incrementar la capacidad cardiorrespiratoria y la tolerancia al ejercicio, y disminuir el perímetro abdominal. Los efectos benéficos obtenidos cambian el pronóstico de la enfermedad coronaria y disminuyen los factores de riesgo metabólicos.AbstractMotivationTo determine the effects of a physical exercise program in the anthropometric characteristics and postsurgical functional capacity after coronary revascularization or percutaneous transluminal coronary angioplasty.MethodsUncontrolled clinical before and after study, in 49 patients who has undergone coronary revascularization or percutaneous transluminal coronary angioplasty. Body mass index, abdominal girth, waist-to-hip ratio, hip perimeter and cardiorespiratory function were assessed by means of the six-minute walk test before and after the physical exercise program. It consisted of continuous aerobic, muscle resistance, balance and coordination exercises three times a week during a total of 12 weeks.ResultsAbdominal girth changed from 91.4cm to 88.4cm (p=0.003) in women and from 93.6cm to 89.8cm (p=0.000). A significant increase of the walked distance was achieved, from 330 to 436 meters (p=0.000); energy use from 3.4 to 4.1 MET (p=0.000); and maximum capacity of absorbing, transporting and consuming oxygen, from 12 to 14ml/Kg/min.ConclusionThe physical activity program used in this study contributed to an increase in all participants of the cardiorespiratory function and exercise tolerance, and to a decrease in abdominal girth. These beneficial effects change the prognosis of the coronary disease and reduce the metabolic risk factors

7 July 2025 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
HAHossam Alzu'BI
Hossam Alzu'BI
ARAnan Abu Rmilah
Anan Abu Rmilah
Hisham BahmadHisham Bahmad
Hisham Bahmad
DJDaniela Urina Jassir
Daniela Urina Jassir
MEMohamad K. Elajami
Mohamad K. Elajami
TETarec K. Elajami
Tarec K. Elajami

1 September 2016 in Revista Colombiana de Cardiología
Verified
Journal Article
Open access
DJDaniela Urina Jassir
Daniela Urina Jassir
MUMiguel Alberto Urina-Triana
Miguel Alberto Urina-Triana
JBJosé Balaguera-Mendoza
José Balaguera-Mendoza
LMLuis Montenegro-Rolong
Luis Montenegro-Rolong
MUManuel Urina-Jassir
Manuel Urina-Jassir
MUManuel Urina-Triana
Manuel Urina-Triana
ResumenIntroducción y ObjetivoEn sujetos con hipertensión arterial sistémica recién diagnosticada es importante verificar la existencia de otros factores de riesgo para enfermedad cardiovascular para poder establecer estrategias para su óptimo tratamiento. Conocer cual es la prevalencia del síndrome metabólico en sujetos con hipertensión arterial sistémica estadio 1.MétodosEstudio prospectivo, observacional, transversal, realizado durante un año en Bogotá, Medellín, Cali y Barranquilla en sujetos de ambos géneros, ≥ 18 años y ≤ 60 años con hipertensión arterial sistémica estadio 1 recién diagnosticada y sin tratamiento farmacológico. A todos los sujetos se les verificó la existencia de síndrome metabólico de acuerdo con el reciente consenso de la Federación Internacional de Diabetes, del Instituto Nacional del Corazón, Pulmón y Sangre, de la Asociación Americana del Corazón, de la Federación Mundial del Corazón, de la Sociedad Internacional de Aterosclerosis y de la Asociación Internacional para el Estudio de la Obesidad.ResultadosLa prevalencia promedio de síndrome metabólico en la población total de hipertensos estudiada fue de 16.84%. En Cali fue de 28.8%, en Medellín fue 18.9%, en Barranquilla fue 12.5% y en Bogotá fue 11.4%. Medellín tuvo la más alta prevalencia en hombres (14.7%) y Cali la mas alta en mujeres (15.2%).ConclusionesEn los sujetos con hipertensión arterial sistémica de reciente diagnóstico se recomienda realizar una búsqueda sistemática del síndrome metabólico. En las ciudades estudiadas de Colombia existió gran variabilidad en la prevalencia del síndrome metabólico encontrada. Se requieren estudios para conocer en otras ciudades de Colombia cual es la prevalencia real del síndrome metabólico en sujetos con hipertensión arterial sistémica en el pais e implementar estrategias educativas para minimizar esta.AbstractIntroduction and motivationIt is important for recently diagnosed systemic hypertension (HPB) individuals to verify the existence of other cardiovascular risk factors, in order to establish optimal treatment strategies. Knowing the prevalence of metabolic syndrome (MS) in patients with stage 1 HBP.MethodsProspective, observational, cross-sectional study conducted over one year in Bogotá, Medellin, Cali and Barranquilla in individuals of both genders, ≥ 18 and ≤ 60 years old with recently diagnosed stage 1 HBP and without drug therapy. Presence of MS was verified for all subjects according to recent consensus of the International Diabetes Federation, the National Heart, Lung and Blood Institute, the American Heart Association, the World Heart Federation, the International Atherosclerosis Society and the International Association for the Study of Obesity.ResultsAverage prevalence of MS in the total population of hypertensive patients was of 16.84%. In Cali it was of 28.8%, in Medellin of 18.9%, in Barranquilla of 12.5% and in Bogotá of 11.4%. Medellin showed the highest prevalence in men (14.7%) and Cali in women (15.2%).ConclusionsIt is recommended to conduct a systematic search for MS in patients who have recently been diagnosed with HBP. Prevalence among MS in the studies Colombian cities varied greatly. More studies are required to find out about the real prevalence of MS in patients with HBP in other Colombian cities and to implement educational studies to minimise its impact